Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 April 2005, Vol. 105, No. 7, pp. 2621.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aledort, L. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Aledort, L. M.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow


InsideBlood

CLINICAL OBSERVATIONS

Comment on Mauser-Bunschoten et al, page 2654

Plug the hole

Louis M. Aledort

MOUNT SINAI SCHOOL OF MEDICINE

This article offers an innovative technique—embolization—for stopping joint hemorrhages in hemophilia patients who do not respond to factor replacement.

Joint bleeding has been the major cause of morbidity for hemophilia patients, frequently requiring surgical intervention for correction and requiring large amounts of replacement therapy with significant financial implications. Profuse bleeding frequently occurs either spontaneously or after joint surgery and may respond poorly to factor replacement.

Mauser-Bunschoten and colleagues present a novel approach to this type of bleeding in 18 patients with 23 major point bleeds. Using angiography and embolization, the results were particularly salutary and controlled bleeding in two thirds of cases with 1 procedure. Bleeding recurred in one third of cases, requiring a second treatment, and 1 case needed 3 such procedures.

These patients had either factor VIII or factor IX deficiency, with or without inhibitors. Almost twice as many cases were seen after joint replacement (within 6 months) and the remainder were spontaneous. None of these bleeding episodes responded to high-dose factor replacement.Go



Blush in a patient with elbow bleeding. See the complete article by Mauser-Bunschoten et al, beginning on page 2654.

 
Selective catheterizations of the popliteal and/or the supragenual and infragenual arteries were carried out and angiograms were done with embolization performed with microcoils. Figure 1A-B dramatically demonstrates the effect of these embolizations. This holds true for either spontaneous or post–joint replacement bleeding.

The authors describe the relatively few complications from this procedure. Arterial spasm and a small thrombus were seen. Joint pain was an accompanying symptom after this therapy. As one would anticipate, one of the inhibitor patients had a significant femoral bleed from the puncture site. Although the authors attribute this to early immobilization, femoral punctures are particularly hazardous in this setting.

Although there have been anecdotal reports of using this technique, this large series is of great interest. It is particularly of note that these types of bleeds occurred both spontaneously and in the post–joint replacement surgical setting. Much energy has been spent on trying to prevent the kind of arthropathy leading to such hemorrhage, using varied prophylactic regimens. Despite these efforts, large numbers of young as well as adult patients remain with substantial joint damage vulnerable to such events. This technology, which the authors appropriately caution should be undertaken only by experienced technologists, offers hemostasis where high-cost, large-volume replacement therapy is ineffective.

As factor concentrates opened the door to rehabilitative surgical intervention for hemophilia arthropathy, this technology offers a way to put the proverbial "finger in the dike." {blacksquare}


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization
Eveline P. Mauser-Bunschoten, Jacco A. C. Zijl, Willem Mali, A. Cees van Rinsum, H. Marijke van den Berg, and Goris Roosendaal
Blood 2005 105: 2654-2657. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aledort, L. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Aledort, L. M.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020